Marianne T. Armstrong
Technik-/Wissenschafts-/F&E-Leiter bei INTERMUNE INC
Aktive Positionen von Marianne T. Armstrong
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INTERMUNE INC | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2002 | - |
General Counsel | 01.04.2002 | - |
Karriereverlauf von Marianne T. Armstrong
Ehemalige bekannte Positionen von Marianne T. Armstrong
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.1999 | 01.04.2002 |
General Counsel | 01.12.1999 | 01.04.2002 | |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.1998 | 01.11.1999 |
AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.1995 | 01.07.1998 |
Ausbildung von Marianne T. Armstrong
Florida State University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
General Counsel | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AMGEN INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
- Börse
- Insiders
- Marianne T. Armstrong
- Erfahrung